CVS - Company ID 0000064803
The table below shows CVS HEALTH Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $4.25B | $4.56B | $4.90B | $7.44B | $3.56B | $2.89B |
| Capital expenditure | $849.00M | $743.00M | $705.00M | $984.00M | $1.05B | $829.00M |
| Investing cash flow | -$874.00M | -$762.00M | -$2.09B | -$8.51B | -$1.99B | -$1.87B |
| Dividends paid | $847.00M | $840.00M | $840.00M | $779.00M |
CVS HEALTH Corp reported operating cash flow of $10.64B for fiscal year 2025. That is up 16.8% from $9.11B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $10.14B (FY 2016) to $10.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $722.00M |
| $656.00M |
| Stock buybacks | - | $0.00 | $3.03B | $2.02B | $2.00B | $0.00 |
| Financing cash flow | -$2.32B | -$2.33B | -$1.23B | $2.73B | -$2.65B | -$3.19B |